Are there Clinical Trials Involving Hyperpolarized Carbon-13?
Yes, several clinical trials are underway to explore the efficacy and safety of hyperpolarized carbon-13 imaging in cancer patients. These studies aim to validate the technique's utility in early detection, tumor characterization, and treatment monitoring. Preliminary results are promising, showing that hyperpolarized carbon-13 can provide valuable metabolic information that complements traditional imaging methods.
